๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This is a multicentric study. All patients with TET (thymic epithelial tumo...
Status
Unknown
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2018-11-01
Trial ID
NCT03921671
Treatments Being Tested
ASP1002 is being studied in people with tumors that have spread to nearby t...
Status
Recruiting
Location
Yale University Cancer Center
Start Date
2023-03-13
Trial ID
NCT05719558
The objective of this study is to compare the progression-free survival (PF...
Status
Completed
Location
ImClone Investigational Site
Start Date
2008-08-06
Trial ID
NCT00703326
Treatments Being Tested
The purpose of this study is to determine whether ramucirumab when used in ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-04
Trial ID
NCT01246960
Treatments Being Tested
An open-label, multicenter, randomized, Phase 2 trial in which participant ...
Status
Completed
Location
ImClone Investigational Site
Start Date
2011-03
Trial ID
NCT01234402
Treatments Being Tested
Previous studies provide a strong theoretical rationale for the conduct of ...
Status
Completed
Location
Institute for Clinical Cancer Research Krankenhaus Nordwest
Start Date
2016-06
Trial ID
NCT02661971
Treatments Being Tested
The treating physician/investigator contacts Lilly when, based on their med...
Status
Approved For Marketing
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
TBD
Trial ID
NCT02065765
Treatments Being Tested
ARMANI-2/ENGIC8 is a randomized, open-label, phase III trial evaluating a s...
Status
Not Yet Recruiting
Location
Krankenhaus Nordwest
Start Date
2026-09-01
Trial ID
NCT07763171
This phase II Lung-MAP treatment trial test the combination of targeted dru...
Status
Recruiting
Location
Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis
Start Date
2023-05-05
Trial ID
NCT05642572
This phase I/II trial studies the side effects and best dose of MM-398 and ...
Status
Withdrawn
Location
USC / Norris Comprehensive Cancer Center
Start Date
2020-04-06
Trial ID
NCT03739801
Treatments Being Tested